#ZeeReadersPoll2020: Arrival of COVID vaccines will end pandemic; do you think this was the biggest news of 2020?
Pfizer-BioNTech and Moderna vaccine uses bits of genetic code to cause an immune response, and is called an mRNA vaccine. (Image Source: Twitter/Reuters)
Updated: Dec 30, 2020, 11:21 PM IST
A year after the COVID-19 pandemic struck the world, several pharmaceutical companies across the world have produced vaccines to counter the virus.
Pfizer-BioNTech and Moderna vaccine uses bits of genetic code to cause an immune response, and is called an mRNA vaccine.
It does not alter human cells, but merely presents the body with instructions to build immunity to COVID.
Oxford s COVID-19 vaccine may not get market approval by Jan: EU regulatory official
The European Medicines Agency s Deputy Executive Director Noel Wathion has said AstraZeneca and the University of Oxford have not filed an application for approval until now
BusinessToday.In | December 30, 2020 | Updated 08:39 IST
In India, the Pune-based Serum Institute of India is developing is manufacturing Oxford s vaccine
The European Medicines Agency, which is the in-charge of authorisation and monitoring of medicinal products in EU countries, might not approve the coronavirus vaccine developed by AstraZeneca and the University of Oxford in January.
According to a report in Reuters, EMA s Deputy Executive Director Noel Wathion has said the duo has not filed an application for approval until now.
After SII s Covishield, Bharat Biotech plans to put its COVID-19 vaccine for approval before expert panel
After SII s Covishield, Bharat Biotech plans to put its COVID-19 vaccine for approval before expert panel
IANSDec 30, 2020, 17:30 IST
BCCL
Bharat Biotech will make a presentation before the
Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) on Wednesday evening for approval of its
vaccine - Covaxin, government sources.
Earlier on Wednesday, the
Serum Institute of India (SII) s application for emergency use authorisation of its Covid-19 vaccine was also considered by the Subject Expert Committee. The development came hours after the United Kingdom accepted the recommendation of the Medicines and Healthcare Regulatory Agency (MHRA) to authorise the Oxford University-AstraZeneca s Covid-19 vaccine,
Centre extends ban on UK flights till 7 Jan, advises caution on New Year s eve; cases of new COVID-19 strain rise to 20 An expert panel met to consider the Emergency Use Authorisation (EUA) requests of Pfizer, Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccine candidates. As per reports, the SEC said it will reconvene on 1 January. FP Staff December 31, 2020 00:00:54 IST Representational image. AFP
The Centre on Wednesday extended the temporary suspension of passenger flights between the United Kingdom and India till 7 January.
This, as 14 more UK returnees tested positive for the new strain of the coronavirus , taking the tally of such cases in the country to 20.
The more infectious UK strain of the coronavirus was first detected in September (File)
Bengaluru:
An apartment complex in Bengaluru has been closed down after two residents - a mother and her daughter - tested positive for the mutated strain of the coronavirus that was first detected in the United Kingdom three months ago.
Both patients, who are among hundreds to have recently returned from the UK, have been admitted to the state-run Victoria Hospital, and primary and secondary contacts have been tested and shifted to institutional quarantine, Karnataka Health Minister Dr K Sudhakar told NDTV.
Dr Sudhakar also played down concern the apartment complex had been sealed - an unsettling reminder of infection protocols in the early days of the pandemic - pointing out the state was only following previously established SOPs (standard operating protocols).